Arena Pharmaceuticals Stock Return On Asset
Arena Pharmaceuticals fundamentals help investors to digest information that contributes to Arena Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Arena Stock. The fundamental analysis module provides a way to measure Arena Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arena Pharmaceuticals stock.
Arena |
Arena Pharmaceuticals Company Return On Asset Analysis
Arena Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Arena Pharmaceuticals Return On Asset | -34.53 |
Most of Arena Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arena Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Arena Pharmaceuticals has a Return On Asset of -34.53. This is 294.63% higher than that of the Healthcare sector and 46.31% higher than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
Arena Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arena Pharmaceuticals' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arena Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arena Pharmaceuticals by comparing valuation metrics of similar companies.Arena Pharmaceuticals is currently under evaluation in return on asset category among related companies.
Arena Fundamentals
| Return On Equity | -70.3 | |||
| Return On Asset | -34.53 | |||
| Current Valuation | 5.36 B | |||
| Shares Outstanding | 61.56 M | |||
| Shares Owned By Insiders | 0.55 % | |||
| Shares Owned By Institutions | 84.05 % | |||
| Number Of Shares Shorted | 5.11 M | |||
| Price To Earning | 4.53 X | |||
| Price To Book | 7.65 X | |||
| Revenue | 54 K | |||
| Gross Profit | (419.45 M) | |||
| EBITDA | (541.79 M) | |||
| Net Income | (616.43 M) | |||
| Cash And Equivalents | 550.47 M | |||
| Cash Per Share | 8.93 X | |||
| Total Debt | 51.31 M | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 8.59 X | |||
| Book Value Per Share | 13.07 X | |||
| Cash Flow From Operations | (452.02 M) | |||
| Short Ratio | 3.83 X | |||
| Earnings Per Share | (9.72) X | |||
| Price To Earnings To Growth | 0.46 X | |||
| Number Of Employees | 448 | |||
| Beta | 0.55 | |||
| Market Capitalization | 6.16 B | |||
| Total Asset | 256.79 M | |||
| Retained Earnings | (1.19 B) | |||
| Working Capital | 124.94 M | |||
| Current Asset | 174.84 M | |||
| Current Liabilities | 49.9 M | |||
| Z Score | 59.8 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arena Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arena Pharmaceuticals' short interest history, or implied volatility extrapolated from Arena Pharmaceuticals options trading.
Pair Trading with Arena Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arena Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arena Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Arena Stock
If you are still planning to invest in Arena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arena Pharmaceuticals' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world |